Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAndom sTArT Ovarian stimUlatIon (RSOS) in eLective oocyte cryopreservation cycLEs (RATATOUILLE)
2023-509919-89-00Phase 4Authorised
- Sponsor
- UZ Brussel
- Start
- Oct 2024
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of recombinant human follicle stimulating hormone, dydrogesterone and triptorelin in female infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Total number of mature cryopreserved oocytes per ovarian stimulation cycle. Planned start Oct 2024; status: authorised.
02
Drugs
recombinant human follicle stimulating hormonedydrogesteronetriptorelin
03
Conditions
female infertility
Beyond the preview
Go deeper on 2023-509919-89-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509919-89-00.